Related Experiment Video
Updated: Apr 16, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
LincRNA-p21 acts as a mediator of ING1b-induced apoptosis
U M Tran1, U Rajarajacholan1, J Soh2
1Department of Biochemistry and Molecular Biology, and Oncology, University of Calgary, 3330 Hospital Drive NW, Calgary, T2N 4N1 Alberta, Canada.
Abstract:
ING1b is a tumor suppressor that affects transcription, cell cycle control and apoptosis. ING1b is deregulated in disease, and its activity is closely linked to that of p53. In addition to regulating protein-coding genes, we found that ING1b also influences the expression of large intergenic non-coding RNAs (lincRNAs). In particular, lincRNA-p21 was significantly induced after DNA-damage stress or by ING1b overexpression. Furthermore, lincRNA-p21 expression in response to DNA damage was significantly attenuated in cells lacking ING1b. LincRNA-p21 is also a target of p53 and can trigger apoptosis in mouse cell models. We found that this function of lincRNA-p21 is conserved in human cell models. Moreover, ING1b and p53 could function independently to influence lincRNA-p21 expression. However, their effects become more additive under conditions of stress. In particular, ING1b regulates lincRNA-p21 levels by binding to its promoter and is required for induction of lincRNA-p21 by p53. The ability of ING1b to cause apoptosis is also impaired in the absence of lincRNA-p21. Surprisingly, deletion of the ING1b plant homeodomain, which allows it to bind histones and regulate chromatin structure, did not alter regulation of lincRNA-p21. Our findings suggest that ING1b induces lincRNA-p21 expression independently of histone 3 lysine 4 trimethylation mark recognition and that lincRNA-p21 functions downstream of ING1b. Thus, regulation at the level of lincRNA-p21 may represent the point at which ING1b and p53 pathways converge to induce apoptosis under specific stress conditions.
Insights
The tumor suppressor ING1b induces large intergenic non-coding RNA-p21 (lincRNA-p21) expression, which is crucial for apoptosis. This pathway converges with p53 to regulate cellular stress responses.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- ING1b is a tumor suppressor involved in transcription, cell cycle control, and apoptosis, with its activity linked to p53.
- ING1b regulates both protein-coding genes and large intergenic non-coding RNAs (lincRNAs).
Purpose of the Study:
- To investigate the role of ING1b in regulating lincRNA expression, specifically lincRNA-p21.
- To elucidate the relationship between ING1b, p53, and lincRNA-p21 in apoptosis induction under stress conditions.
Main Methods:
- Overexpression and knockout studies of ING1b and lincRNA-p21 in human and mouse cell models.
- Analysis of gene expression, promoter binding, and apoptosis assays.
- Investigated the role of the ING1b plant homeodomain in chromatin regulation.
Main Results:
- ING1b overexpression and DNA-damage stress induce lincRNA-p21 expression, which is dependent on ING1b.
- lincRNA-p21 is a p53 target and mediates apoptosis, with ING1b required for p53-induced lincRNA-p21.
- ING1b regulates lincRNA-p21 by binding to its promoter, independently of its histone-binding domain, and lincRNA-p21 functions downstream of ING1b.
Conclusions:
- ING1b induces lincRNA-p21 expression independently of histone modification recognition, suggesting a novel regulatory mechanism.
- lincRNA-p21 acts as a critical mediator in the convergence of ING1b and p53 pathways to induce apoptosis under stress.
- Regulation of lincRNA-p21 represents a key point where ING1b and p53 pathways integrate to control cellular fate.
Related Concept Videos
The Intrinsic Apoptotic Pathway
lncRNA - Long Non-coding RNAs
The Extrinsic Apoptotic Pathway
Negative Regulator Molecules
Experimental RNAi
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...